233 related articles for article (PubMed ID: 33706309)
1. A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.
Morin KA; Parrotta MD; Eibl JK; Marsh DC
Eur Addict Res; 2021; 27(4):268-276. PubMed ID: 33706309
[TBL] [Abstract][Full Text] [Related]
2. A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data.
Morin KA; Eibl JK; Gauthier G; Rush B; Mushquash C; Lightfoot NE; Marsh DC
Harm Reduct J; 2020 Jul; 17(1):51. PubMed ID: 32703310
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada.
Morin KA; Eibl JK; Caswell JM; Rush B; Mushquash C; Lightfoot NE; Marsh DC
PLoS One; 2020; 15(12):e0243317. PubMed ID: 33338065
[TBL] [Abstract][Full Text] [Related]
4. Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.
Gomes T; Campbell TJ; Martins D; Paterson JM; Robertson L; Juurlink DN; Mamdani M; Glazier RH
PLoS Med; 2021 Jun; 18(6):e1003631. PubMed ID: 34061846
[TBL] [Abstract][Full Text] [Related]
5. New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada.
Guan Q; McCormack D; Juurlink DN; Bronskill SE; Wunsch H; Gomes T
JAMA Netw Open; 2021 Nov; 4(11):e2134248. PubMed ID: 34762109
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting.
Eibl JK; Gauthier G; Pellegrini D; Daiter J; Varenbut M; Hogenbirk JC; Marsh DC
Drug Alcohol Depend; 2017 Jul; 176():133-138. PubMed ID: 28535455
[TBL] [Abstract][Full Text] [Related]
7. Concurrent psychiatry for patients enrolled in opioid agonist treatment: a propensity score matched cohort study in Ontario Canada.
Morin KA; Eibl JK; Caswell JM; Gauthier G; Rush B; Mushquash C; Lightfoot NE; Marsh DC
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):29. PubMed ID: 31242949
[TBL] [Abstract][Full Text] [Related]
8. One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis.
Leece P; Chen C; Manson H; Orkin AM; Schwartz B; Juurlink DN; Gomes T
Ann Emerg Med; 2020 Jan; 75(1):20-28. PubMed ID: 31561997
[TBL] [Abstract][Full Text] [Related]
9. Emergency department encounters for opioid abuse, adverse events, poisoning, and dependence among members of a community-based health insurance plan-Central Texas, 2016-2018.
Litaker JR; Tamez N; Durkalski W; Taylor R
BMC Public Health; 2019 Aug; 19(1):1091. PubMed ID: 31409349
[TBL] [Abstract][Full Text] [Related]
10. A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada.
Morin KA; Prevost CR; Eibl JK; Franklyn MT; Moise AR; Marsh DC
PLoS One; 2020; 15(4):e0232191. PubMed ID: 32330184
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of emergency department visits for opioid overdose: a population-based study.
Hasegawa K; Brown DF; Tsugawa Y; Camargo CA
Mayo Clin Proc; 2014 Apr; 89(4):462-71. PubMed ID: 24629443
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.
Tadrous M; Greaves S; Martins D; Nadeem K; Singh S; Mamdani MM; Juurlink DN; Gomes T
Int J Drug Policy; 2019 Apr; 66():82-86. PubMed ID: 30743092
[TBL] [Abstract][Full Text] [Related]
13. Rapid Access Addiction Medicine Clinics for People With Problematic Opioid Use.
Corace K; Thavorn K; Suschinsky K; Willows M; Leece P; Kahan M; Nijmeh L; Aubin N; Roach M; Garner G; Saskin R; Kim E; Rice D; Taha S; Garber G; Hutton B
JAMA Netw Open; 2023 Nov; 6(11):e2344528. PubMed ID: 37991762
[TBL] [Abstract][Full Text] [Related]
14. Hospitalizations and emergency department visits for psychiatric illness during and after pregnancy among women with schizophrenia.
Rochon-Terry G; Gruneir A; Seeman MV; Ray JG; Rochon P; Dennis CL; Grigoriadis S; Fung K; Kurdyak PA; Vigod SN
J Clin Psychiatry; 2016 Apr; 77(4):541-7. PubMed ID: 27035409
[TBL] [Abstract][Full Text] [Related]
15. Medication nonadherence, mental health, opioid use, and inpatient and emergency department use in super-utilizers.
Surbhi S; Graetz I; Wan JY; Gatwood J; Bailey JE
Am J Manag Care; 2020 Mar; 26(3):e98-e103. PubMed ID: 32181622
[TBL] [Abstract][Full Text] [Related]
16. At-a-glance - Hospitalizations and emergency department visits due to opioid poisoning in Canada.
O'Connor S; Grywacheski V; Louie K
Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):244-247. PubMed ID: 29911820
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Acute Health Care Utilization Between Patients Receiving In-Center Hemodialysis and the General Population: A Population-Based Matched Cohort Study From Ontario, Canada.
Naylor KL; Vinegar M; Blake PG; Bota S; Luo B; Garg AX; Ip J; Yeung A; Gingras J; Aziz A; Iskander C; McFarlane P
Can J Kidney Health Dis; 2024; 11():20543581241231426. PubMed ID: 38449711
[TBL] [Abstract][Full Text] [Related]
18. Mortality among patients with frequent emergency department use for alcohol-related reasons in Ontario: a population-based cohort study.
Hulme J; Sheikh H; Xie E; Gatov E; Nagamuthu C; Kurdyak P
CMAJ; 2020 Nov; 192(47):E1522-E1531. PubMed ID: 33229348
[TBL] [Abstract][Full Text] [Related]
19. National trends in population rates of opioid-related mortality, hospitalization and emergency department visits in Canada between 2000 and 2017. A population-based study.
Alsabbagh MW; Chang F; Cooke M; Elliott SJ; Chen M
Addiction; 2021 Dec; 116(12):3482-3493. PubMed ID: 34170044
[TBL] [Abstract][Full Text] [Related]
20. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada.
Kendall CE; Boucher LM; Mark AE; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; Rose T; LeBlanc S; Tyndall M; Lee OM; Bayoumi AM
Harm Reduct J; 2017 May; 14(1):16. PubMed ID: 28494791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
